Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Vandana Singh

Sonoma Pharma Expands Its Partner Network For Oral, Dental Products In US & China

Sonoma Pharmaceuticals Inc (NASDAQ:SNOA) has added Salus Medical as an additional distribution partner in the U.S for dental care.

  • The Company has also expanded its oral and dental care lines to China via a partnership deal with Anlicare International.
  • Sonoma entered into a non-exclusive agreement with Salus Medical to distribute Endocyn root canal irrigant through their existing dental channels. 
  • In addition, Salus Medical will expand on its dermatology offerings with Sonoma's Microcyn RX and Regenacyn Plus products and have non-exclusive distribution rights for Microcyn wound care products.
  • Additionally, Sonoma and Anlicare agreed to cooperate to complete the regulatory work necessary to obtain licenses in China to distribute Sonoma's Microcyn technology-based dental and oral products. 
  • Anlicare will bear the regulatory costs, and in return, Sonoma agreed to grant Anlicare exclusive rights for selling and distributing oral and dental care products in China.
  • In September, Sonoma launched its first OTC products in the U.S. on Amazon and a new consumer-focused product on Amazon in Europe.
  • Price Action: SNOA shares are down 12.2% at $3.73 during the premarket session on the last check Friday.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.